Venous thromboembolism, a condition that includes deep vein thrombosis and pulmonary
embolism, is a significant medical problem that affects more than 1 million patients each …

Background Venous thromboembolic disease has been extensively studied in surgical
patients. The benefit of thromboprophylaxis is now generally accepted, but it is medical …

Background: Despite advances in hospital management in recent years, it is not clear
whether mortality after acute pulmonary embolism (PE) has decreased over time. Objectives …

Background—Clinical predictors for fatal pulmonary embolism (PE) in patients with venous
thromboembolism have never been studied. Methods and Results—Using data from the …

Background Evidence-based guidelines recommend that acutely ill hospitalized medical
patients who are at risk of venous thromboembolism (VTE) should receive prophylaxis. Our …

Patients with venous thromboembolism (VTE), and particularly those with cancer, are at
increased risk of recurrences, major bleeding, and short-/medium-term mortality. Data from …

Objectives: The purpose of this study was to investigate the survival effects of inferior vena
cava filters in patients with venous thromboembolism (VTE) who had a significant bleeding …

Aim: The optimal risk assessment model (RAM) to stratify the risk of venous
thromboembolism (VTE) in medical inpatients is not known. We examined and compared …

Objectives: To examine the clinical characteristics and outcomes of cancer patients with
venous thromboembolism (VTE) in order to identify factors that place these patients at an …

Acutely ill medical patients are at risk of venous thromboembolism (VTE) and VTE-related
mortality during hospitalization and posthospital discharge, but widespread adoption of …